HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Olschewski Selected Research

Iloprost (Ventavis)

3/2009Inhaled iloprost for the treatment of pulmonary hypertension.
4/2008Prostacyclin therapies for the treatment of pulmonary arterial hypertension.
1/2006Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension.
2/2004Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension.
8/2003Zardaverine and aerosolised iloprost in a model of acute respiratory failure.
10/2001Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation.
1/2001Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension.
3/2000Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.
3/2000[Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
1/2000A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Olschewski Research Topics

Disease

17Pulmonary Hypertension
07/2013 - 03/2000
11Pulmonary Arterial Hypertension
12/2014 - 04/2002
5Thrombosis (Thrombus)
03/2009 - 06/2000
5Heart Failure
03/2005 - 03/2000
5Familial Primary Pulmonary Hypertension
12/2003 - 01/2000
2Dyspnea (Shortness of Breath)
09/2019 - 03/2000
2Vascular Diseases (Vascular Disease)
12/2015 - 03/2000
2Vascular Remodeling
11/2002 - 06/2000
2Fibrosis (Cirrhosis)
03/2000 - 03/2000
1Chronic Obstructive Pulmonary Disease (COPD)
09/2019
1Lung Diseases (Lung Disease)
10/2016
1Neoplasms (Cancer)
02/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2015
1Lung Neoplasms (Lung Cancer)
02/2015
1Systemic Scleroderma (Systemic Sclerosis)
11/2014
1Hypoxia (Hypoxemia)
11/2009
1Hypertension (High Blood Pressure)
09/2006
1Autoimmune Hepatitis
09/2006
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
09/2006
1Hepatitis
09/2006
1HIV Infections (HIV Infection)
02/2004
1Telangiectasis (Telangiectasia)
12/2003
1Respiratory Insufficiency (Respiratory Failure)
08/2003
1Disease Progression
12/2001
1Obstructive Sleep Apnea
08/2000
1Hypotension (Low Blood Pressure)
06/2000
1Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2000

Drug/Important Bio-Agent (IBA)

12Epoprostenol (Prostacyclin)FDA LinkGeneric
03/2009 - 03/2000
10Iloprost (Ventavis)FDA Link
03/2009 - 01/2000
8ProstaglandinsIBA
10/2016 - 06/2000
6Vasodilator Agents (Vasodilators)IBA
11/2004 - 03/2000
5Sildenafil Citrate (Viagra)FDA Link
04/2008 - 11/2002
3Oxygen (Dioxygen)IBA
11/2014 - 03/2000
3AnticoagulantsIBA
12/2006 - 06/2000
2CollagenIBA
12/2015 - 03/2000
2Transforming Growth Factor beta (TGF-beta)IBA
12/2003 - 12/2001
2Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2002 - 01/2000
1Sympathomimetics (Sympathomimetic Amines)IBA
09/2019
1Endothelin Receptor AntagonistsIBA
10/2016
1Phosphodiesterase 5 InhibitorsIBA
10/2016
1Protein Isoforms (Isoforms)IBA
02/2015
1Glucose (Dextrose)FDA LinkGeneric
02/2015
1PhosphoenolpyruvateIBA
02/2015
1Imatinib Mesylate (Gleevec)FDA Link
12/2014
1Clostridium perfringens epsilon-toxinIBA
11/2014
1prednylidene (Pred)IBA
11/2009
1treprostinilFDA Link
04/2008
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2006
1EndoglinIBA
12/2003
1Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA
12/2003
1zardaverineIBA
08/2003
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
08/2003
115-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA
08/2003
1Guanosine Monophosphate (5' Guanylic Acid)IBA
04/2002
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
12/2001
1DiureticsIBA
12/2001
1Phosphodiesterase InhibitorsIBA
12/2001
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
12/2001
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
12/2001
1Atrial Natriuretic Factor (ANF)IBA
10/2001
1Superoxides (Superoxide)IBA
08/2000
1Fibrinolytic Agents (Antithrombotic Agents)IBA
06/2000
1CalciumIBA
03/2000

Therapy/Procedure

12Therapeutics
12/2014 - 03/2000
1Intravenous Infusions
04/2008
1Subcutaneous Infusions
04/2008
1Endarterectomy (Thromboendarterectomy)
11/2007